News articles about Mindray Medical International (NYSE:MR) have trended somewhat positive recently, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Mindray Medical International earned a media sentiment score of 0.22 on Accern’s scale. Accern also gave media coverage about the medical instruments supplier an impact score of 46.7960235945489 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

These are some of the headlines that may have impacted Accern Sentiment’s rankings:

Shares of Mindray Medical International (NYSE:MR) remained flat at $27.94 during midday trading on Friday. Mindray Medical International has a 52 week low of $21.80 and a 52 week high of $33.83. The stock’s 50 day moving average price is $27.20 and its 200 day moving average price is $25.81.

TRADEMARK VIOLATION NOTICE: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at

Mindray Medical International Company Profile

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature.

Insider Buying and Selling by Quarter for Mindray Medical International (NYSE:MR)

Receive News & Stock Ratings for Mindray Medical International Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd and related stocks with our FREE daily email newsletter.